Depression im Alter – Diagnostik, Pathophysiologie und therapeutische Strategien

Forugh S. Dafsari; Frank Jessen

doi:10.1055/a-0847-9170

Geriatrie up2date, Table of Contents

Geriatrie up2date 2019; 1(02): 135-148
DOI: 10.1055/a-0847-9170

Neurologie und Psychiatrie

Georg Thieme Verlag KG Stuttgart · New York

Depression im Alter – Diagnostik, Pathophysiologie und therapeutische Strategien

Authors

Forugh S. Dafsari
Frank Jessen

Abstract

All articles of this category

Depressionen zählen zu den häufigsten psychischen Erkrankungen im höheren Lebensalter. Sie führen zu einer starken Inanspruchnahme von Gesundheitsleistungen und gehen mit erhöhter Morbidität und Mortalität einher. Mit Blick auf den demografischen Wandel stellt die Altersdepression eine große Herausforderung der alternden Gesellschaft dar. Der frühzeitigen Diagnostik und spezifischen Behandlung kommt eine besondere Bedeutung zu.

Schlüsselwörter

Altersdepression - kognitive Defizite - Antidepressiva - Psychotherapie - EKT

Full Text

References

Literatur
1 Volkert J, Schulz H, Härter M. et al. The prevalence of mental disorders in older people in Western countries – a meta-analysis. Ageing Res Rev 2013; 12: 339-353
2 Luppa M, Sikorski C, Luck T. et al. Age- and gender-specific prevalence of depression in latest-life – systematic review and meta-analysis. J Affect Disord 2012; 136: 212-221
3 DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW. Hrsg. für die Leitliniengruppe Unipolare Depression S3-Leitlinie/Nationale Versorgungs-Leitlinie Unipolare Depression – Langfassung, 2. Aufl. Version 4; 2015. Im Internet: http://www.depression.versorgungsleitlinien.de Stand: 31.01.2017
4 Teresi J, Abrams R, Holmes D. et al. Prevalence of depression and depression recognition in nursing homes. Soc Psychiatry Psychiatr Epidemiol 2001; 36: 613-620
5 Busch MA, Maske UE, Ryl L. et al. Prävalenz von depressiver Symptomatik und diagnostizierter Depression bei Erwachsenen in Deutschland – Ergebnisse der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1). Bundesgesundheitsbl 2013; 56: 733-739
6 Riedel-Heller SG, Luppa M. Depression im Alter – was trägt die aktuelle epidemiologische Forschung bei?. Psychiat Prax 2013; 40: 173-175
7 Koenig AM, Bhalla RK, Butters MA. Cognitive Functioning and Late-Life Depression. J Int Neuropsychol Soc 2014; 20: 461-467
8 Chan J, Draper B, Banerjee S. Deliberate self-harm in older adults: a review of the literature from 1995 to 2004. Int J Geriatr Psy 2007; 22: 720-732
9 Statistisches Bundesamt Gesundheit. Todesursachen in Deutschland 2015. (Januar 2017). Im Internet: https://www.destatis.de/DE/Publikationen/Thematisch/Gesundheit/Todesursachen/Todesursachen2120400157004.pdf?__blob=publicationFile Stand: 19.12.2017
10 Härter M, Baumeister H, Reuter K. et al. Increased 12-month prevalence rates of mental disorders in patients with chronic somatic diseases. Psychother Psychosom 2007; 76: 354-360
11 Katon W, Lin EH, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry 2007; 29: 147-155
12 Luppa M, Sikorski C, Motzek T. et al. Health Service Utilization and Costs of Depressive Symptoms in Late Life – A Systematic Review. Curr Pharm Des 2012; 18: 1-23
13 Hegeman JM, Kok RM, van der Mast RC. et al. Phenomenology of depression in older compared with younger adults: meta-analysis. Br J Psychiatry 2012; 200: 275-281
14 Wolter DK. Depressionen im höheren Lebensalter, Teil 1. Entstehung, klinische Symptome, Diagnose und Wechselwirkung zwischen Depression und Demenz. Z Gerontol Geriat 2016; 49: 335-348
15 Ownby RL, Crocco E, Acevedo A. et al. Depression and Risk for Alzheimer Disease. Systematic Review, Meta-analysis, and Metaregression Analysis. Arch Gen Psychiatry 2006; 63: 530-538
16 Almeida OP, Hankey GJ, Yeap BB. et al. Depression as a modifiable factor to decrease the risk of dementia. Transl Psychiatry 2017; 7: 1-6
17 Singh-Manoux A, Dugravot A, Fournier A. et al. Trajectories of Depressive Symptoms before Diagnosis of Dementia. A 28-Year Follow-up Study. JAMA Psy 2017; 74: 712-718
18 Mirza SS, Wolters FJ, Swanson SA. et al. 10-year trajectories of depressive symptoms and risk of dementia: a population-based study. Lancet Psy 2016; 3: 628-635
19 Aziz R, Steffens DC. What Are the Causes of Late-Life Depression?. Psychiatr Clin North Am 2013; 36: 497-516
20 Cole MG, Dendukuri N. Risk Factors for Depression Among Elderly Community Subjects: A Systematic Review and Meta-Analysis. Am J Psychiatry 2003; 160: 1147-1156
21 Vink D, Aartsen MJ, Schoevers RA. Risk factors for anxiety and depression in the elderly: A review. J Affect Disord 2008; 106: 29-44
22 Hautzinger M. Depression im Alter: Psychotherapeutische Behandlung für das Einzel- und Gruppensetting. 2. Aufl.. Weinheim: Beltz; 2016
23 Tsang RS, Mather KA, Sachdev PS. et al. Systematic review and meta-analysis of genetic studies of late-life depression. Neurosci Biobehav Rev 2017; 75: 129-139
24 Sierksma AS, van den Hove DL, Steinbusch HW. et al. Major depression, cognitive dysfunction and Alzheimerʼs disease: Is there a link?. Eur J Pharmacol 2010; 626: 72-82
25 Hermida AP, McDonald WM, Steenland K. et al. The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link?. Expert Rev Neurother 2012; 12: 1339-1350
26 Lanfumey L, Mongeau R, Cohen-Salmon C. et al. Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders. Neurosci Biobehav Rev 2008; 32: 1174-1184
27 Drevets WC, Frank E, Price JC. et al. PET Imaging of Serotonin 1A Receptor Binding in Depression. Biol Psychiatry 1999; 46: 1375-1387
28 López-Figueroa AL, Norton CS, López-Figueroa MO. et al. Serotonin 5-HT1A, 5-HT1B, and 5-HT2A Receptor mRNA Expression in Subjects with Major Depression, Bipolar Disorder, and Schizophrenia. Biol Psychiatry 2004; 55: 225-233
29 Mattson MP, Maudsley S, Martin B. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci 2004; 27: 589-594
30 Wei N, Yong W, Li X. et al. Post-stroke depression and lesion location: a systematic review. J Neurol 2015; 262: 81-90
31 Benjamin S, Steffens DC. Structural Neuroimaging of Geriatric Depression. Psychiatr Clin North Am 2011; 34: 423-435
32 Koolschijn PC, van Haren NE, Lensvelt-Mulders GJ. et al. Brain Volume Abnormalities in Major Depressive Disorder: A Meta-Analysis of Magnetic Resonance Imaging Studies. Hum Brain Mapp 2009; 30: 3719-3735
33 Taylor WD, Macfall JR, Payne ME. et al. Orbitofrontal cortex volume in late life depression: influence of hyperintense lesions and genetic polymorphisms. Psychol Med 2007; 37: 1763-1773
34 Steffens DC, Byrum CE, McQuoid DR. et al. Hippocampal volume in geriatric depression. Biol Psychiatry 2000; 48: 301-309
35 De Winter FL, Emsell L, Bouckaert F. et al. No Association of Lower Hippocampal Volume with Alzheimerʼs Disease Pathology in Late-Life Depression. Am J Psy 2017; 174: 237-245
36 Gunning FM, Smith GS. Functional neuroimaging in geriatric depression. Psychiatr Clin North Am 2011; 34: 403-422
37 Nascimento KK, Silva KP, Malloy-Diniz LF. et al. Plasma and cerebrospinal fluid amyloid-β levels in late-life depression: A systematic review and meta-analysis. J Psychiatr Res 2015; 69: 35-41
38 Wu KY, Hsiao IT, Chen CS. et al. Increased brain amyloid deposition in patients with a lifetime history of major depression: evidenced on 18F-florbetapir (AV-45/Amyvid) positron emission tomography. Eur J Nucl Med Mol Imaging 2014; 41: 714-722
39 Bschor T, Bauer M, Adli M. Chronische und therapieresistente Depression – Diagnostik und Stufentherapie. Dtsch Arztebl Int 2014; 111: 766-776
40 Benkert O, Hippius H. Kompendium der Psychiatrischen Pharmakotherapie. 10. Aufl.. Heidelberg: Springer; 2014
41 Tedeschini E, Levkovitz Y, Iovieno N. et al. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials. J Clin Psy 2011; 72: 1660-1668
42 Gibbons RD, Hur K, Brown CH. et al. Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. Arch Gen Psy 2012; 69: 572-579
43 Heilmann KE, Wagner M, Riedel-Heller S. et al. Medikamentöse Behandlung der Depression im Alter – Empfehlungen aus Internationalen Leitlinien und aktueller Literatur. Fortschr Neurol Psychiatr 2015; 83: 381-391
44 Heun R, Ahokas A, Boyer P. et al. The efficacy of agomelatine in elderly patients with recurrent major depressive disorder: a placebo-controlled study. J Clin Psych 2013; 74: 587-594
45 Wilson K, Mottram P, Sivanranthan A. et al. Antidepressant versus placebo for depressed elderly. Cochrane Database Syst Rev 2001; (02) CD000561
46 Strobach D. Klinisch relevante Interaktionen zwischen Analgetika und Psychopharmaka. Arzneimittelther 2012; 30: 83-92
47 Gillmann PK. A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action. Biol Psychiatry 2006; 59: 1046-1051
48 Schenk M, Wirz S. Serotoninsyndrom und medikamentöse Schmerztherapie – Was ist für die Praxis relevant?. Schmerz 2015; 29: 229-251
49 Letmaier M, Grohmann R, Kren C. et al. Venous thromboembolism during treatment with antipsychotics: Results of a drug surveillance programme. World J Biol Psychiatry 2018; 19: 175-186
50 Jackson JW, Schneeweiss S, VanderWeele TJ. et al. Quantifying the role of adverse events in the mortality difference between first and second-generation antipsychotics in older adults: systematic review and meta-synthesis. PLoS One 2014; 9: e105376
51 Kleijer BC, van Marum RJ, Egberts AC. et al. Risk of cerebrovascular events in elderly users of antipsychotics. J Psychopharmacol 2009; 23: 909-914
52 Percudani M, Barbui C, Fortino I. et al. Second-Generation Antipsychotics and Risk of Cerebrovascular Accidents in the Elderly. J Clin Psychopharmacol 2005; 25: 468-470
53 Wu CS, Wang SC, Gau SS. et al. Association of stroke with the receptor-binding profiles of antipsychotics-a case-crossoverstudy. Biol Psychiatry 2013; 73: 414-421
54 Gühne U, Luppa M, König HH. et al. Ist Psychotherapie bei depressiven Erkrankungen im Alter wirksam? Ein systematischer Überblick. Psychiat Prax 2014; 41: 415-423
55 Cuijpers P, van Straten A, Smit F. Psychological treatment of late-life depression: a meta-analysis of randomized controlled trials. Int J Geriatr Psychiatry 2006; 21: 1139-1149
56 Gould RL, Coulson MC, Howard RJ. Cognitive behavioral therapy for depression in older people: a meta-analysis and meta-regression of randomized controlled trials. J Am Geriatr Soc 2012; 60: 1817-1830
57 Krishna M, Jauhari A, Lepping P. et al. Is group psychotherapy effective in older adults with depression? A systematic review. Int J Geriatr Psychiatry 2011; 26: 331-340
58 Kiosses DN, Leon AC, Areán PA. Psychosocial interventions for late-life major depression: evidence-based treatments, predictors of treatment outcomes, and moderators of treatment effects. Psychiatr Clin North Am 2011; 34: 377-401
59 Wolter DK. Depressionen im höheren Lebensalter. Teil 2: Komorbidität und Behandlung. Z Gerontol Geriat 2016; 49: 437-452
60 OʼConnor MK, Knapp R, Husain M. et al. The influence of age on the response of major depression to electroconvulsive therapy: a C.O.R.E. Report. Am J Geriatr Psychiatry 2001; 9: 382-390
61 Spaans HP, Sienaert P, Bouckaert F. et al. Speed of remission in elderly patients with depression: electroconvulsive therapy v. medication. Br J Psychiatry 2015; 206: 67-71